Articles tagged with: CTIC
Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) recently released their second quarter figures for 2009 and stated it was a transforming quarter for the company, in which they eliminated 44.5% of their outstanding debt. They also released …
Justin Hall a blogger from SeekingAlpha says the FDA Calendar “should be free”in a recent blog entry.
After reading this I decided to check out Justin profile, since I have never heard of him, and I …
Reading some of the posts on the Yahoo message boards I see a lot of people talking about Hemispherix Biopharma (AMEX:HEB)trading is now halted. Obviously this is not true since the stock is not on the …